Dapiglutide for the Treatment of Obesity

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Dapiglutide for the Treatment of Obesity	Body Weight, Inflammation, Nutritional and Metabolic Diseases, Overweight, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutrition	Active, not recruiting	Phase 2	2024-12-05		NCT05788601

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
University Hospital, Gentofte, Copenhagen	16
Zealand Pharma	11

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Center for Clinical Metabolic Research, Herlev-Gentofte Hospital	Hellerup	Denmark	2

Clinical trials